Products

News

Echelon Biosciences sub-awarded DoD grant to develop drugs to thwart Impact of trauma, stroke, and Cardiac arrest

Contributed by admin on Sep 13, 2016 - 06:13 PM
Mark Nelson Ph.D., of Echelon Biosciences will be the principal investigator, to synthesize and test drugs to protect the brain and other organs in the body from ischemia and reperfusion injury (IRI).

Full story here

FRONTIER SCIENTIFIC ACQUIRES PREMIER AG INDUSTRY SUPPLIER

Contributed by admin on Aug 11, 2014 - 11:51 AM

Echelon Biosciences acquires California Peptide Research

Contributed by admin on Apr 28, 2014 - 05:44 PM
Salt Lake City - Echelon Biosciences, Inc. (EBI) announces the acquisition of California Peptide Research, Inc. (CPRI) to offer its line of biochemicals and research peptides, and to further drive innovations in the growing peptide research and development markets.

ASDI Inc. assets acquired by Frontier Scientific Services Inc.

Contributed by admin on Sep 09, 2011 - 01:02 PM
assay and reagents for drug discovery in lipid signaling pathways